TOBI PODHALER (Tobramycin Inhalation Powder) 28 mg per capsule home
  • Skip to Main Content
  • Full Prescribing Information
  • Patient Product Information
  • Important Safety Information
  • For HCPs
  • Sign Up
  • Treating Your Pa
  • About TOBI PODHALER
  • Getting Started
  • Savings
  • Patient Stories & Resources
  • Sign Up

TOBI® PODHALER® Savings Card Terms and Conditions

With this Savings Card, you may pay as little as $0 for each 28-day fill of TOBI® PODHALER® (Tobramycin Inhalation Powder), while this program remains in effect. This Savings Card may be used to reduce the amount of your out-of-pocket costs for TOBI PODHALER up to the full amount of your out-of-pocket cost per 28-day prescription, up to an aggregate maximum of $14,000 per calendar year while this program remains in effect. No other purchase is necessary. Valid prescription with Prescriber ID# is required. Viatris Specialty LLC reserves the right to amend or end this program at any time without notice.

Eligibility Requirements: This Savings Card can be redeemed only by patients or patient guardians who are 18 years of age or older and who are residents of the United States and its territories. Patients must have commercial insurance with coverage for TOBI PODHALER. This program is not valid for uninsured patients or commercially insured patients without coverage for TOBI PODHALER; not valid for patients who are covered by any state or federally funded healthcare program, including but not limited to any state pharmaceutical assistance program, Medicare (Part D or otherwise), Medicaid, Medigap, VA or DOD, or TRICARE (regardless of whether TOBI PODHALER is covered by such government program); not valid if the patient is Medicare-eligible and enrolled in an employer-sponsored health plan or prescription benefit program for retirees; and not valid if the patient’s insurance plan is paying the entire cost of this prescription. This program is void outside the US and its territories or where prohibited by law, taxed, or restricted, and may not be available in all states.

This Savings Card is not health insurance. This Savings Card is not transferable, and the amount of the savings cannot exceed the patient’s out-of-pocket costs. This Savings Card cannot be combined with any other rebate/coupon, cash discount card, free trial, or other offer for the specified prescription. This Savings Card is not redeemable for cash.

NOTICE: Data related to your use of this Savings Card may be collected, analyzed and shared with Viatris Specialty LLC for market research and other purposes related to assessing its savings card programs. Data shared with Viatris Specialty LLC will be aggregated and de-identified, meaning it will be combined with data related to other savings card redemptions and will not identify you.

Patient Instructions: By using this Savings Card, you hereby accept and agree to abide by these terms and conditions. Further, you acknowledge and agree that you currently meet the eligibility criteria and other requirements described herein every time you use this Savings Card and that you understand and will comply with the following additional terms and conditions:

  • You have not submitted and will not submit a claim for reimbursement under any federal, state or other governmental programs for this prescription.
  • Your use of this Savings Card must be consistent with the terms of any drug benefit provided by your commercial health insurer, health plan, or private third-party payer. You agree to report the use of this Savings Card to your commercial insurer if required.
  • Where required, a Savings Card and prescription drug insurance card, along with a valid prescription for TOBI PODHALER must be presented to your pharmacist.
  • Should you begin receiving prescription benefits from any government funded program, you will withdraw from this Savings Card program.

Pharmacist Instructions: When you accept this Savings Card, you are certifying that you have received this Savings Card from an eligible patient; you have received a valid prescription for TOBI PODHALER for an eligible patient; you have dispensed the product as indicated; you have not submitted and will not submit a claim for reimbursement under any federal, state or other governmental programs for this prescription; and you will otherwise comply with these terms and all applicable terms and conditions. You further certify that your participation in otherwise, that you have as a pharmacy provider, and that you will report the use of this Savings Card to the patient’s insurer if required.

  • Submit transaction to McKesson Corporation using BIN #610524.
  • For commercially insured patients, input this Savings Card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable patient savings will be displayed in the transaction response. Cash Discount Cards are not valid as primary insurance under this offer.
  • Acceptance of this Savings Card and your submission of claims for the TOBI PODHALER Savings Card program are subject to the Savings Card Terms and Conditions posted at https://www.tobipodhaler.com/savings-card-terms-and-conditions.
  • Acceptance of this Savings Card and your submission of claims for the TOBI PODHALER Savings Card program are subject to the LoyaltyScript® program Terms and Conditions posted at www.mckesson.com/mprstnc.
  • For questions regarding setup, claim transmission, patient eligibility or other issues, call the LoyaltyScript® for the TOBI PODHALER Savings Card program at 800-657-7613 (8:00 AM-8:00 PM EST, Monday-Friday).

INDICATION: TOBI® PODHALER® (Tobramycin Inhalation Powder) 28 mg per capsule and TOBI® (Tobramycin Inhalation Solution) are prescription inhaled medications for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. It is not known if TOBI PODHALER or TOBI are safe and effective in patients under 6 years of age, in those with lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia.

IMPORTANT SAFETY INFORMATION

Do not swallow TOBI PODHALER capsules. TOBI PODHALER capsules are used only with the Podhaler device and inhaled through your mouth (oral inhalation). Never place a capsule in the mouthpiece of the Podhaler device.

You should not use TOBI PODHALER or TOBI if you are allergic to tobramycin, any of the ingredients, or to any other aminoglycoside antibacterial medicines.

Before using TOBI PODHALER or TOBI, tell your healthcare provider about all of your medical conditions, including if you have or have had hearing problems; dizziness; kidney problems; muscle weakness; breathing problems such as wheezing, coughing, or chest tightness; if you have had an organ transplant; are pregnant or nursing or plan to become pregnant or nurse; or if you are receiving aminoglycoside therapy by injection or through a vein. Also, tell your healthcare provider if your mother has had hearing problems after taking an aminoglycoside or if you have been told you have certain gene variants related to hearing abnormalities inherited from your mother.

TOBI PODHALER and TOBI contain a medicine that can harm your unborn baby. It is not known if it passes into breast milk. Check your baby for watery stools, bloody stools, thrush, or diaper rash if you breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using TOBI Podhaler or TOBI with certain other medicines can cause serious side effects. If you are using TOBI PODHALER or TOBI, discuss if you should take other medicines that may harm your nervous system, kidneys, or hearing; "water pills" (diuretics) such as EDECRIN® (ethacrynic acid), LASIX® (furosemide), or intravenous mannitol; or urea.

TOBI PODHALER and TOBI can cause serious side effects, including:

  • Severe breathing problems (bronchospasm). Tell your healthcare provider right away if you get shortness of breath with wheezing or coughing and chest tightness while using TOBI PODHALER or TOBI.
  • Hearing loss or ringing in the ears (ototoxicity). Tell your healthcare provider right away if you have hearing loss, noises in your ears such as ringing or hissing, vertigo, difficulty with balance, or dizziness.
  • Worsening kidney problems (nephrotoxicity). TOBI PODHALER and TOBI are in a class of medicines that may cause worsening kidney problems, especially in people with known or suspected kidney problems. Your healthcare provider may do a blood test to check how your kidneys are working while you are using TOBI PODHALER or TOBI.
  • Worsening muscle weakness. TOBI PODHALER and TOBI are in a class of medicines that can cause worsening muscle weakness in people who already have problems with muscle weakness (myasthenia gravis or Parkinson's disease).

The most common side effects of TOBI PODHALER include cough, worsening of lung problems or cystic fibrosis, productive cough, shortness of breath, fever, sore throat, changes in your voice (hoarseness), coughing up blood, and headache.

The most common side effects of TOBI include increased cough, coughing up blood, voice changes, sore throat, decreased lung function, loss or change in taste, increased sputum, trouble breathing, and rash.

Let your healthcare provider know if your symptoms worsen or if you have a side effect that bothers you enough to stop treatment or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information and Patient Information for TOBI PODHALER.
Please see Full Prescribing Information and Patient Information for TOBI Solution.

TOBI<sup>®</sup> 
PODHALER<sup>®</sup> (Tobramycin Inhalation Powder) 28 mg per capsule TOBI<sup>®</sup> PODHALER<sup>®</sup> 
(Tobramycin Inhalation Powder) 28 mg per capsule

You are leaving www.TOBIPODHALER.com/

By clicking “continue” below, you are leaving this site to arrive on a third-party site that is solely responsible for its content.

Continue
Cancel

Stay in
the know

Sign up to stay connected with TOBI® PODHALER.®

Stay in the know

*Please enter your first name.
*Please enter your last name.
*Please enter a valid email address. *Please enter a valid email address.

Error while submitting the form

By signing up, you authorize Viatris Inc. and trusted parties acting on its behalf, to send you the TOBI PODHALER materials you requested and other commercial communications from Viatris Inc. By enrolling, you confirm that you are a resident of the United States and over 18 years of age.

Viatris Inc. understands that your personal and health information are private. To learn about how Viatris Inc. uses your information, please view our Privacy Notice.

*Required field

Thank you for
signing up!

We’ll send you the latest about TOBI PODHALER, delivered right to your inbox.

TOBI<sup>®</sup> 
PODHALER<sup>®</sup> (Tobramycin Inhalation Powder) 28 mg per capsule TOBI<sup>®</sup> PODHALER<sup>®</sup> 
(Tobramycin Inhalation Powder) 28 mg per capsule

This site is intended for US healthcare professionals.

By clicking “Continue” you acknowledge that you are a US healthcare professional.

Continue
Cancel

Sign up now

Please enter your first name.
Please enter your last name.
Please enter a valid email address. Please enter a valid email address.

I am:

Please select a checkbox.

Error while submitting the form

By clicking the "Submit" button below, you will automatically be enrolled to receive updates.

Intended for US residents only. Mylan Specialty L.P., a Viatris Company, understands that your personal and health information is private. The information you provide will only be used by Mylan Specialty L.P., a Viatris Company, and parties acting on its behalf to send you the materials you requested and other helpful information and updates on this product, as well as related treatments, products, offers and service. You may remove yourself from this mailing list at any time by clicking “unsubscribe” on any e-newsletters or other communications that you receive. To learn about how Viatris uses your information, please view our Privacy Statement.

US-NON-2024-00068

All fields are required.

Thanks for joining us. We’ll be in touch.

Viatris website
  • Call Us
    Call Us
  • Instagram
    Follow Us
  • Facebook
    Follow Us
  • Email
    Sign Up
Patients and caregivers depicted on this website have been paid by Viatris to share their stories.

TOBI, PODHALER, the Tobi Logo, and PODCARE+ are registered trademarks of BGP Products Operations GmbH, a Viatris Company.

PULMOSPHERE is a registered trademark of Novartis AG, licensed to the Viatris Companies. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company. All other product names and registered trademarks are property of their respective owners.

© 2026 Viatris Inc. All Rights Reserved.

Use of website is governed by the Terms of Use and Privacy Notice.

  • Cookie Notice
  • California Supplemental Disclosure
  • Site Map
  • Contact Us

US-TOBI-2024-00049 V3

Expand

INDICATION: TOBI® PODHALER® (Tobramycin Inhalation Powder) 28 mg per capsule and TOBI® (Tobramycin Inhalation Solution) are prescription inhaled medications for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. It is not known if TOBI PODHALER or TOBI are safe and effective in patients under 6 years of age, in those with lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia.

IMPORTANT SAFETY INFORMATION

Do not swallow TOBI PODHALER capsules. TOBI PODHALER capsules are used only with the Podhaler device and inhaled through your mouth (oral inhalation). Never place a capsule in the mouthpiece of the Podhaler device.

You should not use TOBI PODHALER or TOBI if you are allergic to tobramycin, any of the ingredients, or to any other aminoglycoside antibacterial medicines.

Before using TOBI PODHALER or TOBI, tell your healthcare provider about all of your medical conditions, including if you have or have had hearing problems; dizziness; kidney problems; muscle weakness; breathing problems such as wheezing, coughing, or chest tightness; if you have had an organ transplant; are pregnant or nursing or plan to become pregnant or nurse; or if you are receiving aminoglycoside therapy by injection or through a vein. Also, tell your healthcare provider if your mother has had hearing problems after taking an aminoglycoside or if you have been told you have certain gene variants related to hearing abnormalities inherited from your mother.

TOBI PODHALER and TOBI contain a medicine that can harm your unborn baby. It is not known if it passes into breast milk. Check your baby for watery stools, bloody stools, thrush, or diaper rash if you breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using TOBI Podhaler or TOBI with certain other medicines can cause serious side effects. If you are using TOBI PODHALER or TOBI, discuss if you should take other medicines that may harm your nervous system, kidneys, or hearing; "water pills" (diuretics) such as EDECRIN® (ethacrynic acid), LASIX® (furosemide), or intravenous mannitol; or urea.

TOBI PODHALER and TOBI can cause serious side effects, including:

  • Severe breathing problems (bronchospasm). Tell your healthcare provider right away if you get shortness of breath with wheezing or coughing and chest tightness while using TOBI PODHALER or TOBI.
  • Hearing loss or ringing in the ears (ototoxicity). Tell your healthcare provider right away if you have hearing loss, noises in your ears such as ringing or hissing, vertigo, difficulty with balance, or dizziness.
  • Worsening kidney problems (nephrotoxicity). TOBI PODHALER and TOBI are in a class of medicines that may cause worsening kidney problems, especially in people with known or suspected kidney problems. Your healthcare provider may do a blood test to check how your kidneys are working while you are using TOBI PODHALER or TOBI.
  • Worsening muscle weakness. TOBI PODHALER and TOBI are in a class of medicines that can cause worsening muscle weakness in people who already have problems with muscle weakness (myasthenia gravis or Parkinson's disease).

The most common side effects of TOBI PODHALER include cough, worsening of lung problems or cystic fibrosis, productive cough, shortness of breath, fever, sore throat, changes in your voice (hoarseness), coughing up blood, and headache.

The most common side effects of TOBI include increased cough, coughing up blood, voice changes, sore throat, decreased lung function, loss or change in taste, increased sputum, trouble breathing, and rash.

Let your healthcare provider know if your symptoms worsen or if you have a side effect that bothers you enough to stop treatment or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information and Patient Information for TOBI PODHALER.
Please see Full Prescribing Information and Patient Information for TOBI Solution.